Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications

Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications

Peptide hormones of the glucagon-like peptide (GLP) family play an increasing clinical role, such as GLP-1 in diabetes therapy. Moreover, GLP receptors are over-expressed in various human tumor types and therefore represent molecular targets for important clinical applications. In particular, virtua...

Full description

Bibliographic Details
Main Authors: Meike eKörner, Emanuel eChrist, Damian eWild, Jean Claude eReubi
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-12-01
Series:Frontiers in Endocrinology
Subjects:
Insulinoma
somatostatin receptors
Glucagon-like peptide-1
Glucagon-like petide-1 receptor
111In-DOTA/DPTA-exendin-4.
Online Access:http://journal.frontiersin.org/Journal/10.3389/fendo.2012.00158/full

Similar Items

Similar Items